Stock A195940 HK INNO.N CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus HK inno.N Corporation

Equities

A195940

KR7195940002

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
38,750 KRW -1.27% Intraday chart for HK inno.N Corporation +2.51% -12.82%
2022 Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights from HK inno.N Corporation to Develop and Commercialize Tegoprazan in the U.S. and Canada CI
2022 Sebela Pharmaceuticals Enters an Exclusive Partnership with HK inno.N Corporation CI

Evolution of the average Target Price on HK inno.N Corporation

Price target over the last 5 years

History of analyst recommendation changes

e45b05.pQ0IepPbyCmbtUvu7bqgqXKWeoLCMkpby3yxZ44Ici4.x3d4P6aDsUrdg3q6osCVzR_kNvWLeDMQmzflEsNQG3SQWXII8J66bvP-OA~131b1301aa4ef9985ca34acb2ec5c705

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
38,750 KRW
Average target price
53,750 KRW
Spread / Average Target
+38.71%
High Price Target
61,000 KRW
Spread / Highest target
+57.42%
Low Price Target
48,000 KRW
Spread / Lowest Target
+23.87%

Consensus detail

Consensus revision (last 18 months)

Ratings for HK inno.N Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A195940 Stock
  4. Consensus HK inno.N Corporation